Segui
Luigi Buonaguro
Luigi Buonaguro
National Cancer Institute Pascale, Naples IT
Email verificata su istitutotumori.na.it
Titolo
Citata da
Citata da
Anno
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation
B Ensoli, L Buonaguro, G Barillari, V Fiorelli, R Gendelman, RA Morgan, ...
Journal of virology 67 (1), 277-287, 1993
9721993
Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications
L Buonaguro, ML Tornesello, FM Buonaguro
Journal of virology 81 (19), 10209-10219, 2007
5682007
HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
HC Chang, F Samaniego, BC Nair, L Buonaguro, B Ensoli
Aids 11 (12), 1421-1431, 1997
5591997
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines
L Buonaguro, G Barillari, HK Chang, CA Bohan, V Kao, R Morgan, ...
Journal of virology 66 (12), 7159-7167, 1992
3751992
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ...
The Lancet infectious diseases 19 (2), 143-155, 2019
3172019
Translating tumor antigens into cancer vaccines
L Buonaguro, A Petrizzo, ML Tornesello, FM Buonaguro
Clinical and Vaccine Immunology 18 (1), 23-34, 2011
2972011
Antimicrobial peptides as anticancer agents: functional properties and biological activities
AL Tornesello, A Borrelli, L Buonaguro, FM Buonaguro, ML Tornesello
Molecules 25 (12), 2850, 2020
2492020
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
G Barillari, L Buonaguro, V Fiorelli, J Hoffman, F Michaels, RC Gallo, ...
Journal of immunology (Baltimore, Md.: 1950) 149 (11), 3727-3734, 1992
2401992
Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies
F Pezzuto, L Buonaguro, F Caponigro, F Ionna, N Starita, C Annunziata, ...
Oncology 89 (3), 125-136, 2015
2182015
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
ML Tornesello, L Buonaguro, F Tatangelo, G Botti, F Izzo, FM Buonaguro
Genomics 102 (2), 74-83, 2013
1832013
Antigen-specific vaccines for cancer treatment
M Tagliamonte, A Petrizzo, ML Tornesello, FM Buonaguro, L Buonaguro
Human vaccines & immunotherapeutics 10 (11), 3332-3346, 2014
1802014
The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer
ML Tornesello, R Faraonio, L Buonaguro, C Annunziata, N Starita, ...
Frontiers in oncology 10, 150, 2020
1732020
Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer
ML Tornesello, L Buonaguro, P Giorgi-Rossi, FM Buonaguro
BioMed research international 2013, 2013
1722013
The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure
L Buonaguro, FM Buonaguro, G Giraldo, B Ensoli
Journal of virology 68 (4), 2677-2682, 1994
1551994
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses
L Buonaguro, ML Tornesello, M Tagliamonte, RC Gallo, LX Wang, ...
Journal of virology 80 (18), 9134-9143, 2006
1492006
High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts
N Scotti, F Alagna, E Ferraiolo, G Formisano, L Sannino, L Buonaguro, ...
Planta 229, 1109-1122, 2009
1352009
Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro
CA Bohan, F Kashanchi, B Ensoli, L Buonaguro, KA Boris-Lawrie, ...
Gene expression 2 (4), 391, 1992
1301992
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated endometrial cancers: new candidates for checkpoint blockade immunotherapy?
P Gargiulo, C Della Pepa, S Berardi, D Califano, S Scala, L Buonaguro, ...
Cancer treatment reviews 48, 61-68, 2016
1252016
Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix
ML Tornesello, S Losito, G Benincasa, F Fulciniti, G Botti, S Greggi, ...
Gynecologic oncology 121 (1), 32-42, 2011
1142011
Developments in virus-like particle-based vaccines for infectious diseases and cancer
L Buonaguro, M Tagliamonte, ML Tornesello, FM Buonaguro
Expert review of vaccines 10 (11), 1569-1583, 2011
1082011
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20